Skip to main content

Table 3 Clinical characteristics and outcomes in intervention group and control group patients after 3 months

From: Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study

 

Intervention group

Control group

T-value

Sig.

Mean (S.D.)

Mean (S.D.)

General overuse

12.17 (2.19)

12.69 (2.62)

1.583

0.115

General harm

10.61 (2.37)

10.77 (2.93)

0.467

0.641

Beneficial effect of pharmaceuticals

14.91 (1.99)

15.11 (2.15)

0.708

0.480

Beliefs about medicines

36.84 (3.77)

38.43 (4.46)

2.855

0.005a

Sensitive

15.40 (2.61)

15.47 (3.11)

0.165

0.869

Necessity beliefs

18.73 (3.78)

18.46 (4.19)

0.509

0.611

Concern beliefs

12.42 (3.18)

13.25 (4.00)

1.694

0.092

Treatment Satisfaction Questionnaire for Medication (TSQM)

86.68 (11.08)

82.82 (13.40)

2.326

0.021a

Estimated weights for EQ-5D

0.66 (0.39)

0.65 (0.38)

0.076

0.939

Montgomery–Åsberg Depression Scale

21.07 (12.21)

21.01 (12.63)

0.036

0.971

Medication Adherence Scale

5.79 (1.89)

5.04 (1.98)

2.880

0.004a

  1. aSignificantly different